Estimate average blood glucose levels from A1C results to help translate longer-term glucose control into an understandable average glucose value.
Assess an individual’s risk of developing type 2 diabetes using the Canadian CANRISK questionnaire.
Compare diabetes medications by key characteristics to support treatment discussions and medication selection.
Explore an individualized approach to setting A1C targets based on the person’s clinical circumstances, risks and treatment goals.
Support shared decision-making by comparing diabetes medication options based on factors that matter to individual patients. A tool by Mayo Clinic
Assess physical activity and support practical conversations about incorporating exercise and movement into type 2 diabetes care. A tool by Diabetes Canada
Access guidance and tools to support appropriate screening and diagnosis of diabetes and prediabetes.
Support decisions about self-monitoring of blood glucose (SMBG), including when monitoring may be appropriate and how results can inform care.
Support shared decision-making about statin therapy using Mayo Clinics risk aid, and use it with your patients in discussion on cardiovascular benefits and risks.
Explore pharmacological treatment options for type 2 diabetes and support individualized treatment decisions.
Assess cardiovascular and vascular risk in people with diabetes to help guide prevention and risk-reduction strategies.